CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $2.73B, above the global median of $1.15B
- FinancialsAltman Z-Score 6.01: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.73BUSDvs all stocks (USD)
Revenue (TTM)
183.99MUSDvs all stocks (USD)
Profit Margin
-91.84%Beta
2.81xvs all stocks
52-Week Change
-46.41%vs all stocks
Market Capitalization
2.73BUSDvs all stocks (USD)
Enterprise Value
2.52BUSDvs all stocks (USD)
Forward P/E
-52.25xPrice to Sales (TTM)
14.85xPrice to Book (MRQ)
5.80xEnterprise to Revenue
13.70xEnterprise to EBITDA
-16.00xGross Margin
31.09%Profit Margin
-91.84%Operating Margin
-139.30%Return on Assets (TTM)
-19.67%Return on Equity (TTM)
-39.40%Revenue (TTM)
183.99MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4460USDUpdated Jul 19, 2026Quarterly Revenue Growth
51.70%Gross Profit (TTM)
74.67MUSDvs all stocks (USD)
EBITDA (TTM)
-157.62MUSDvs all stocks (USD)
Net Income (TTM)
-168.26MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
51.72%Operating Cash Flow (TTM)
-105.30MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-16.69MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
168.92MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
97.37MUSDFY2025 · Dec 31, 2025Gross Profit
71.55MUSDFY2025 · Dec 31, 2025Operating Income
-186.40MUSDvs all stocks (USD)
Pre-tax Income
-9.27MUSDFY2025 · Dec 31, 2025Income Tax Expense
4.73MUSDFY2025 · Dec 31, 2025Net Income
-14.01MUSDFY2025 · Dec 31, 2025EBIT
-8.60MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-139.37MUSDFY2025 · Dec 31, 2025Research & Development
98.25MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
143.83MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
9.80MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
670.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0300USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.2800USDFY2025 · Dec 31, 2025Basic Shares Outstanding
405.42MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
405.42MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-14.01MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-88.72MUSDFY2025 · Dec 31, 2025Free Cash Flow
-89.63MUSDDerived from operating cash flow minus capital expenditure. This filing charges 37.04M of depreciation against 902K of capital expenditure, and its own free-cash-flow line reads -103.12M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
249.17MUSDFY2025 · Dec 31, 2025Income Tax Paid
4.37MUSDFY2025 · Dec 31, 2025Interest Paid
26.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-14.01MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
37.04MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
1.34MUSDFY2025 · Dec 31, 2025Stock-based Compensation
80.62MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-159.55MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-23.72MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.93MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-12.37MUSDFY2025 · Dec 31, 2025Capital Expenditures
-902.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
-54.60MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-55.50MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-169.00KUSDFY2025 · Dec 31, 2025Other Financing Charges
-4.23MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
207.96MUSDFY2025 · Dec 31, 2025Shares Outstanding
426.28MSharesUpdated Jul 19, 2026Float Shares
393.21MSharesUpdated Jul 19, 2026Shares Short
162.88MSharesUpdated Jul 19, 2026Short Ratio
6.15daysvs all stocks
Short % of Shares Outstanding
41.07%vs all stocks
% Held by Insiders
1.12%vs all stocks
% Held by Institutions
44.63%vs all stocks
Total Cash (MRQ)
215.64MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.4980USDUpdated Jul 19, 2026Total Debt (MRQ)
6.23MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0135xCurrent Ratio (MRQ)
3.94xBook Value per Share (MRQ)
1.08USDUpdated Jul 19, 2026Total Assets
688.17MUSDvs all stocks (USD)
Total Current Assets
329.13MUSDFY2025 · Dec 31, 2025Total Liabilities
224.39MUSDFY2025 · Dec 31, 2025Total Non-current Assets
359.04MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
152.65MUSDFY2025 · Dec 31, 2025Total Current Liabilities
71.74MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
248.49MUSDFY2025 · Dec 31, 2025Accounts Receivable
32.34MUSDFY2025 · Dec 31, 2025Accounts Payable
10.56MUSDFY2025 · Dec 31, 2025Short-term Debt
2.14MUSDFY2025 · Dec 31, 2025Deferred Revenue
24.04MUSDFY2025 · Dec 31, 2025Other Current Liabilities
6.00MUSDFY2025 · Dec 31, 2025Long-term Debt
2.07MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
138.77MUSDFY2025 · Dec 31, 2025Common Stock (Book)
40.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-957.07MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
463.79MUSDvs all stocks (USD)
52-Week Low
5.83USDUpdated Jul 19, 202652-Week High
22.17USDUpdated Jul 19, 202652-Week Change
-46.41%vs all stocks
Beta
2.81xvs all stocks
50-Day MA
7.55USDUpdated Jul 19, 2026200-Day MA
10.16USDUpdated Jul 19, 2026Avg 10-Day Volume
31.50MSharesUpdated Jul 19, 2026Avg 30-Day Volume
27.48MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-0.7000USDUpdated Jul 19, 2026Other Income / Expense
168.00MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.01: safe zoneNotable
Altman Z-Score: 6.01
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $2.73B, above the global median of $1.15BNotable
Market cap (USD): 2,731,677,108Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Alarm.com Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Goto Gojek Tokopedia Tbk.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
LiveRamp Holdings, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
SoftwareOne Holding AG
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
monday.com Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Q2 Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Wix.com Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Evercommerce Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
CCC Intelligent Solutions Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Urban Company Limited
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Wave Life Sciences Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Sealsq Corp
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Enovix Corporation
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC